Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small cell lung cancer.

CONCLUSIONS: Among physicians ordering VeriStrat, the test significantly influenced treatment recommendations for patients with NSCLC, reducing ineffective and expensive treatment at the end-of-life. PMID: 28277859 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28277859?dopt=Abstract

Source: Current Medical Research and Opinion - March 10, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research